Taken together, Oncomine and GEPIA databases jointly suggested that the mRNA expression of MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, and MT2A was significantly downregulated in patients with HCC. The gene discussed is MT1M; the disease is hepatocellular carcinoma.